AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

Clinical trial NCT05632328 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05632328
Sponsor: Bruno Bockorny
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma Pancreatic Cancer

Start date: 2024-08-08
Primary completion: 2026-08-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.